Profile data is unavailable for this security.
About the company
China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.
- Revenue in HKD (TTM)19.47bn
- Net income in HKD1.38bn
- Incorporated1992
- Employees17.30k
- LocationChina Traditional Chinese Medicine Holdings Co LtdRoom 1601, Emperor Group Centre288 Hennessy RoadWanchai Hong KongHKG
- Phone+852 28543393
- Fax+852 25441269
- Websitehttps://www.china-tcm.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Luye Pharma Group Ltd | 6.60bn | 572.15m | 10.61bn | 5.27k | 18.45 | 0.788 | 7.96 | 1.61 | 0.1529 | 0.1529 | 1.77 | 3.58 | 0.247 | 2.42 | 3.60 | 1,252,222.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SciClone Pharmaceuticals (Holdings) Ltd | 3.39bn | 1.21bn | 11.80bn | 1.05k | 10.11 | 3.22 | 8.67 | 3.48 | 1.85 | 1.85 | 5.21 | 5.81 | 0.7585 | 3.56 | 3.83 | 3,228,498.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
| Shanghai Henlius Biotech Inc | 5.80bn | 586.56m | 12.42bn | 3.64k | 21.23 | 5.27 | 12.77 | 2.14 | 1.08 | 1.08 | 10.62 | 4.33 | 0.5731 | 1.95 | 9.10 | 1,593,481.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| SSY Group Ltd | 6.46bn | 1.32bn | 12.65bn | 5.60k | 9.62 | 1.82 | 7.23 | 1.96 | 0.4427 | 0.4427 | 2.17 | 2.33 | 0.5637 | 3.00 | 3.01 | 1,154,109.00 | 11.59 | 10.51 | 15.58 | 14.03 | 56.01 | 58.72 | 20.57 | 18.62 | 1.60 | 29.61 | 0.317 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| Zai Lab Ltd | 2.27bn | -2.65bn | 13.17bn | 2.18k | -- | 2.16 | -- | 5.79 | -2.73 | -2.73 | 2.35 | 6.12 | 0.2697 | 2.84 | 5.61 | -- | -31.41 | -37.72 | -36.81 | -42.72 | 62.86 | 64.75 | -116.45 | -282.44 | 4.43 | -- | 0.0596 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
| Simcere Pharmaceutical Group Ltd | 7.10bn | 767.83m | 14.07bn | 7.03k | 19.20 | 1.86 | 12.79 | 1.98 | 0.288 | 0.288 | 2.72 | 2.97 | 0.6106 | 3.53 | 2.65 | 1,010,167.00 | 6.60 | 10.17 | 8.94 | 15.60 | 75.43 | 78.82 | 10.80 | 17.50 | 1.87 | 0.9742 | 0.1652 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
| The United Laboratories Intl. Hldgs Ltd. | 14.76bn | 2.90bn | 15.06bn | 15.00k | 5.19 | 1.10 | 4.29 | 1.02 | 1.60 | 1.60 | 8.12 | 7.53 | 0.6871 | 3.36 | 6.15 | 984,005.60 | 13.51 | 7.89 | 20.52 | 12.64 | 46.11 | 44.17 | 19.66 | 12.73 | 1.74 | -- | 0.1055 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
| 3SBio Inc | 8.40bn | 1.66bn | 15.19bn | 5.41k | 9.45 | 1.01 | 7.36 | 1.81 | 0.6708 | 0.6708 | 3.44 | 6.29 | 0.3426 | 1.58 | 7.01 | 1,551,706.00 | 6.95 | 7.44 | 9.03 | 9.29 | 84.98 | 82.91 | 20.30 | 21.50 | 2.26 | 22.72 | 0.2266 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| China Medical System Holdings Ltd | 8.61bn | 2.58bn | 15.98bn | 5.70k | 6.23 | 0.9633 | 5.69 | 1.86 | 1.05 | 1.05 | 3.51 | 6.80 | 0.4517 | 3.42 | 6.19 | 1,509,960.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| Grand Pharmaceutical Group Ltd | 10.53bn | 1.88bn | 16.79bn | 10.53k | 8.83 | 1.09 | 7.34 | 1.59 | 0.5356 | 0.5356 | 3.00 | 4.33 | 0.4692 | 2.94 | 10.26 | 999,581.40 | 8.45 | 10.09 | 11.66 | 14.01 | 61.96 | 61.97 | 18.00 | 22.35 | 0.9819 | 22.96 | 0.1831 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| China Traditional Chinese Med Hldg CoLtd | 19.47bn | 1.38bn | 18.48bn | 17.30k | 13.39 | 0.813 | 6.88 | 0.9494 | 0.2742 | 0.2742 | 3.87 | 4.51 | 0.4985 | 1.47 | 2.16 | 1,125,090.00 | 3.84 | 4.60 | 5.85 | 7.07 | 51.18 | 57.07 | 7.70 | 9.77 | 1.48 | 9.83 | 0.1773 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
| WuXi XDC Cayman Inc | 2.28bn | 304.59m | 19.10bn | 1.18k | 57.26 | 3.26 | 51.88 | 8.37 | 0.2784 | 0.2784 | 2.12 | 4.89 | -- | -- | -- | 1,936,789.00 | -- | -- | -- | -- | 26.35 | -- | 13.35 | -- | 4.03 | -- | 0.0005 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
| HUTCHMED (China) Ltd | 6.54bn | 787.06m | 23.74bn | 1.99k | 30.37 | 4.16 | 27.82 | 3.63 | 0.8973 | 0.8973 | 7.61 | 6.55 | 0.7258 | 7.19 | 7.69 | 3,292,013.00 | 8.76 | -14.35 | 13.36 | -20.43 | 54.12 | 36.57 | 12.06 | -31.44 | 2.60 | -- | 0.1038 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
Data as of Jul 05 2024. Currency figures normalised to China Traditional Chinese Medicine Holdings Co Ltd's reporting currency: Hong Kong Dollar HKD
23.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ping An of China Asset Management (Hong Kong) Co., Ltd.as of 30 Jun 2023 | 604.30m | 12.00% |
| UBS Asset Management Switzerland AGas of 18 Jun 2024 | 315.49m | 6.27% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 93.07m | 1.85% |
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 64.42m | 1.28% |
| BlackRock Fund Advisorsas of 06 Jun 2024 | 32.16m | 0.64% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 28.14m | 0.56% |
| UBS Asset Management (Americas) LLCas of 18 Jun 2024 | 22.09m | 0.44% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 19.11m | 0.38% |
| Bankinter Gesti�n de Activos SA SGIICas of 30 Jun 2023 | 12.32m | 0.25% |
| BlackRock Advisors (UK) Ltd.as of 06 Jun 2024 | 8.86m | 0.18% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
